Industry Case Studies
Each case study takes one recent deal, partnership, or launch in clinical research and works through what it means for sponsors, sites, and investors.
Latest Case Studies
These are analyses of public events, not client engagements. Each one sets out what happened, why it matters, and what the people affected can do about it.
PSI and Appian Automate Site Selection: Faster Process, Same Data Question
On October 28, 2026, PSI CRO and Appian launched an AI-driven workflow for identifying and selecting trial sites. It is one of several such launches this year. For sponsors, the useful question is not how fast the process runs but what data it runs on.
Ryght AI's Free Site Search: Your Site Is Being Ranked, Whether You Take Part or Not
In April 2026, Ryght AI launched a free search engine that ranks clinical trial sites worldwide, and in May ASCO began using Ryght's platform to choose sites for a breast cancer study. Sites are now being profiled and ranked from data they did not supply.
Fengate and Clinical Research of West Florida: What a Platform Buyer Needs to Know About a Site
In October 2026, Fengate Private Equity took a majority stake in Clinical Research of West Florida, a 30-year-old Tampa Bay site business, with plans to build a regional network around it. The deal is a useful example of what a buyer has to verify before treating a site as a platform.
Summit and Dallas Research Institute: Buying Therapeutic Depth, One Site at a Time
In September 2026, Summit Clinical Research Solutions added Dallas Research Institute, a two-year-old metabolic and liver disease site, to its Pinnacle network. The deal shows how specialist networks grow, and why a young site is hard to assess from the outside.
Headlands Research Changes Hands: Does Consolidation Make Sites Better?
THL Partners agreed in August 2025 to buy Headlands Research from KKR, moving one of the largest site networks from one private equity owner to another. Buyers say scale brings consistency. Critics say it brings risk. Sponsors need a way to tell, site by site.
How We Write These
Our case studies are information first. The analysis has to stand on its own before we say anything about our own products.
The Tools Behind the Analysis
SiteScore™ verifies and benchmarks clinical research site performance. FeasComplete™ helps sites answer feasibility requests faster.